Express Pharma

JANUARY 14, 2024

Recombinant technology is the manipulation of the host genome by adding a foreign altered gene vector to produce new genetic combinations that are of value to science, health, and industry. Here, the introduced gene vector is the recombinant gene, usually added to change the phenotype of an organism. To achieve genetically modified organisms (GMOs), isolation of pure DNA, cutting at recognised locations of DNA to get the desired gene, amplification of the desired gene using polymerase chain reac

Documentation 116

Documentation 116

The Guardian - Pharmaceutical Industry

JANUARY 14, 2024

Unpublished figures reveal a doubling of products in short supply over past two years ‘The worst I’ve known it’: the struggle to get vital medicines Analysis: why is UK being hit by medicine supply shortages? An unprecedented medicines shortage in the NHS is endangering lives, pharmacists have said, as unpublished figures reveal that the number of products in short supply has doubled in two years.

Diabetes 111

Diabetes 111

Express Pharma

JANUARY 14, 2024

ENTOD Pharmaceuticals has launched ‘FUR’, a division to provide eye and ear care medicines for pets. The product portfolio of FUR by ENTOD encompasses a wide range of veterinary eye and ear care solutions, from lubricating drops to anti-glaucoma medications, anti-allergies, antibiotics, and combinations. FUR by ENTOD products is set to be available not only in the domestic market but also to their international partners and customers.

96

96

The Guardian - Pharmaceutical Industry

JANUARY 14, 2024

Four people with conditions that require consistent medication explain how the shortages have affected their wellbeing NHS medicines shortage putting people at risk, pharmacists warn Analysis: why is UK being hit by medicine supply shortages? More people in the UK are struggling to access vital medicines than ever before, exacerbating conditions from epilepsy to the menopause.

90

90

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

JANUARY 14, 2024

FDA has opened a comment period until January 31 on how digital health technologies (DHTs) may be deployed to help prevent, detect and manage diabetes

Diabetes 91

Diabetes 91

Drug Patent Watch

JANUARY 14, 2024

Annual Drug Patent Expirations for NUPLAZID Nuplazid is a drug marketed by Acadia Pharms Inc and is included in two NDAs. It is available from one supplier. There are fourteen… The post New patent expiration for Acadia Pharms drug NUPLAZID appeared first on DrugPatentWatch - Make Better Decisions.

59

59

Drug Patent Watch

JANUARY 14, 2024

Annual Drug Patent Expirations for SECUADO Secuado is a drug marketed by Hisamitsu and is included in one NDA. It is available from one supplier. There are five patents protecting… The post New patent for Hisamitsu drug SECUADO appeared first on DrugPatentWatch - Make Better Decisions.

59

59

PharmaState Academy

JANUARY 14, 2024

Episode 22 - Pharma Journey of Parul Sood | Humans of Pharma In Episode 22 of the Pharma Journey Series, we will get to know more about the inspirational journey of Ms. Parul Sood. With over a decade and a half of prolific experience in pharmaceutical sales and marketing. She embodies the epitome of confidence, ambition, and performance-driven leadership within the dynamic realm of healthcare.

Biosimilars 52

Biosimilars 52

Drug Patent Watch

JANUARY 14, 2024

Annual Drug Patent Expirations for AUGTYRO Augtyro is a drug marketed by Bristol and is included in one NDA. It is available from one supplier. The generic ingredient in AUGTYRO… The post New patent for Bristol drug AUGTYRO appeared first on DrugPatentWatch - Make Better Decisions.

59

59

Med Ed 101

JANUARY 14, 2024

Fenofibrate is a lipid-lowering medication indicated as monotherapy to treat primary hyperlipidemia, mixed dyslipidemia, and hypertriglyceridemia. While this medication has been around for many years, its formulation has continued to evolve. The different fenofibrate formulations can get confusing, especially when terms such as micronized, nanoparticles, and solid dispersions get thrown into the mix.

52

52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Drug Patent Watch

JANUARY 14, 2024

Annual Drug Patent Expirations for EPRONTIA Eprontia is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are two patents protecting… The post New patent for Azurity drug EPRONTIA appeared first on DrugPatentWatch - Make Better Decisions.

59

59

Pharmaceutical Business Review

JANUARY 14, 2024

This agreement focuses on treating fourth-line gastrointestinal stromal tumours (GIST) in adult patients. The territories covered under the deal include Croatia, Bulgaria, Czech Republic, Cyprus, Greece, Estonia, Latvia, Lithuania, Hungary, Malta, Romania, Poland, Slovakia, and Slovenia. A switch-control inhibitor of Deciphera, Ripretinib is approved in the EU for adults with advanced GIST.

59

59

Drug Patent Watch

JANUARY 14, 2024

Annual Drug Patent Expirations for DIFICID Dificid is a drug marketed by Cubist Pharms Llc and is included in two NDAs. It is available from one supplier. There are six… The post New patent expiration for Cubist Pharms drug DIFICID appeared first on DrugPatentWatch - Make Better Decisions.

59

59

Drug Patent Watch

JANUARY 14, 2024

This chart shows the pharmaceutical companies with the most cream dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most cream dosed drugs… The post Which pharmaceutical companies have the most cream dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Dosage 59